88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control Breakthrough preclinical data demonstrate that LiCO-saUcp1 effectively turns white fat into calorie-burning brown fat, driving massive fat loss while fully preserving lean muscle mass and preventing post-treatment ... 2026-06-06T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver Clinical Study Showed Up to 48% Natural Killer Cell Increase with probiotic strain LP28 1 ... 2026-06-06T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Eratrectinib, the next-generation TRK inhibitor independently developed by Vcare PharmaTech, has received marketing approval NANJING, China , June 5, 2026 /PRNewswire/ -- NTRK gene fusions have been identified as oncogenic drivers in adult and pediatric patients with pan-solid tumors. A fusion gene is typically formed by the ... 2026-06-05T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Mabwell's 9MW5211 Receives IND Clearance from NMPA for Inflammatory Bowel Disease SHANGHAI , June 5, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its independently developed ... 2026-06-05T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility SINGAPORE , June 5, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has completed the topping ... 2026-06-05T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Natural Field Announces New Cartilage Health Research Findings Ahead of CPHI China 2026 XI'AN, China , June 4, 2026 /PRNewswire/ -- Natural Field recently completed a Phase I scientific evaluation study on joint health functionality. The results demonstrated that glucosamine-chondroitin ... 2026-06-04T Biotechnology Food/Beverages Health Care/Hospital
Global Ergothioneine Market Poised for Accelerated Growth as Scientific Validation and Synthetic Biology Reshape Industry Dynamics New Frost & Sullivan White Paper Highlights Emerging Opportunities Across Healthy Aging, Functional Nutrition, Personal Care, and Preventive Healthcare ... 2026-06-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Soonr Health Officially Launches in the U.S. with Connected At-Home Fertility Tracking for Couples With the launch of Surearly SMART on Amazon, Soonr Health now offers couples connected at-home ovulation and hormone testing, the first device in an expanding ecosystem built around dyadic health. ... 2026-06-04T Biotechnology Health Care/Hospital Household/Consumer/Cosmetics
Stronger Together, Shaping the Future \| WuXi XDC and BioDlink Successfully Concluded 2026 Open Day WuXi XDC and BioDlink jointly hosted the 2026 Open Day, marking their first flagship customer-facing event following the strategic integration. The event brought together biotech customers, industry ... 2026-06-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Innovative Drug Update \| Kexing Biopharm Enrolls First Subject in China-based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10 SHENZHEN, China , June 4, 2026 /PRNewswire/ -- Recently, the first subject was enrolled and dosed in the Phase I clinical trial in China for GB10 Injection, an innovative ophthalmic drug independently ... 2026-06-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved